DGAP-Ad-hoc: Continental AG / Key word(s): Personnel After more than eleven years in office, the CEO of Continental AG Dr. Elmar Degenhart (61) has informed the Supervisory Board today about his intention to resign from his mandate for reasons of immediately necessary preventive health care effective November 30, 2020. He has asked the Supervisory Board to accept the early termination of his Executive Board mandate and his contract, which would have run until August 11, 2024. Supervisory Board Chairman Professor Wolfgang Reitzle has announced that he will convene the Supervisory Board shortly to decide on the appointment of the successor to Degenhart. Degenhart, who holds a doctorate in engineering, has been CEO of the company since August 12, 2009, and is currently in his third term. He is directly responsible for Group Communications, Group Strategy, Group Total Quality Management and the start-up program co-pace. Contact: Person making the notification: Bernard Wang, Head of IR
29-Oct-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Continental AG |
Vahrenwalder Straße 9 | |
30165 Hannover | |
Germany | |
Phone: | +49 (0)511 938-1068 |
Fax: | +49 (0)511 938-1080 |
E-mail: | ir@conti.de |
Internet: | www.continental-corporation.com/de |
ISIN: | DE0005439004 |
WKN: | 543900 |
Indices: | DAX |
Listed: | Regulated Market in Frankfurt (Prime Standard), Hamburg, Hanover, Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Tradegate Exchange; Luxembourg Stock Exchange, SIX |
EQS News ID: | 1144149 |
End of Announcement | DGAP News Service |
|
1144149 29-Oct-2020 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.